Can the 'love hormone' calm anxiety in diabetes insipidus?
NCT ID NCT06036004
First seen Jan 09, 2026 · Last updated Jun 16, 2026 · Updated 20 times
Summary
This study tests whether a nasal spray containing oxytocin can help reduce anxiety and improve emotional well-being in adults with central diabetes insipidus, a condition where the body lacks a key hormone. Participants will receive either oxytocin or a placebo spray for several weeks. The goal is to see if oxytocin can ease psychological symptoms beyond standard hormone replacement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL DIABETES INSIPIDUS (CDI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité University Medical Center Berlin
RECRUITINGBerlin, 10117, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Erasmus University Medical Center Rotterdam
RECRUITINGRotterdam, 3015, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Basel, Department of Endocrinology, Diabetes & Metabolism
RECRUITINGBasel, 4031, Switzerland
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.